Why Is Oculis Stock Sinking Monday?

Oculis Holding AG (NASDAQ:OCS) stock is down on Monday after the company announced disappointing results from its Phase 3 DIAMOND trials for its OCS-01 eye drops aimed at treating diabetic macular edema. Oculis (OCS) Stock Drops After DIAMOND Phase 3 Miss The...